The economic burden of cancers attributable to metabolic syndrome in Korea

Dongwoo Kim, Seok-Jun Yoon, Young Hoon Gong, Young Ae Kim, Hye Young Seo, Jihyun Yoon, A. Rim Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea. Methods: We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers' costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death. Results: In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively. Conclusions: We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.

Original languageEnglish
Pages (from-to)180-187
Number of pages8
JournalJournal of Preventive Medicine and Public Health
Volume48
Issue number4
DOIs
Publication statusPublished - 2015 Jan 1

Fingerprint

Korea
Economics
Neoplasms
Costs and Cost Analysis
Premature Mortality
Insurance
Health Care Costs
Caregivers
Hospitalization
Outpatients

Keywords

  • Economic burden
  • Metabolic syndrome
  • Neoplasm

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

The economic burden of cancers attributable to metabolic syndrome in Korea. / Kim, Dongwoo; Yoon, Seok-Jun; Gong, Young Hoon; Kim, Young Ae; Seo, Hye Young; Yoon, Jihyun; Kim, A. Rim.

In: Journal of Preventive Medicine and Public Health, Vol. 48, No. 4, 01.01.2015, p. 180-187.

Research output: Contribution to journalArticle

Kim, Dongwoo ; Yoon, Seok-Jun ; Gong, Young Hoon ; Kim, Young Ae ; Seo, Hye Young ; Yoon, Jihyun ; Kim, A. Rim. / The economic burden of cancers attributable to metabolic syndrome in Korea. In: Journal of Preventive Medicine and Public Health. 2015 ; Vol. 48, No. 4. pp. 180-187.
@article{937ec8a5acb8476389996130f6b6acc1,
title = "The economic burden of cancers attributable to metabolic syndrome in Korea",
abstract = "Objectives: Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea. Methods: We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers' costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death. Results: In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively. Conclusions: We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.",
keywords = "Economic burden, Metabolic syndrome, Neoplasm",
author = "Dongwoo Kim and Seok-Jun Yoon and Gong, {Young Hoon} and Kim, {Young Ae} and Seo, {Hye Young} and Jihyun Yoon and Kim, {A. Rim}",
year = "2015",
month = "1",
day = "1",
doi = "10.3961/jpmph.15.022",
language = "English",
volume = "48",
pages = "180--187",
journal = "Journal of Preventive Medicine and Public Health",
issn = "1975-8375",
publisher = "Korean Society for Preventive Medicine",
number = "4",

}

TY - JOUR

T1 - The economic burden of cancers attributable to metabolic syndrome in Korea

AU - Kim, Dongwoo

AU - Yoon, Seok-Jun

AU - Gong, Young Hoon

AU - Kim, Young Ae

AU - Seo, Hye Young

AU - Yoon, Jihyun

AU - Kim, A. Rim

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objectives: Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea. Methods: We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers' costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death. Results: In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively. Conclusions: We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.

AB - Objectives: Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea. Methods: We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers' costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death. Results: In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively. Conclusions: We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.

KW - Economic burden

KW - Metabolic syndrome

KW - Neoplasm

UR - http://www.scopus.com/inward/record.url?scp=84938872737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938872737&partnerID=8YFLogxK

U2 - 10.3961/jpmph.15.022

DO - 10.3961/jpmph.15.022

M3 - Article

VL - 48

SP - 180

EP - 187

JO - Journal of Preventive Medicine and Public Health

JF - Journal of Preventive Medicine and Public Health

SN - 1975-8375

IS - 4

ER -